BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16307475)

  • 1. Rational engineering of a fluorescein-binding anticalin for improved ligand affinity.
    Vopel S; Mühlbach H; Skerra A
    Biol Chem; 2005 Nov; 386(11):1097-104. PubMed ID: 16307475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystallographic analysis of an "anticalin" with tailored specificity for fluorescein reveals high structural plasticity of the lipocalin loop region.
    Korndörfer IP; Beste G; Skerra A
    Proteins; 2003 Oct; 53(1):121-9. PubMed ID: 12945055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duocalins: engineered ligand-binding proteins with dual specificity derived from the lipocalin fold.
    Schlehuber S; Skerra A
    Biol Chem; 2001 Sep; 382(9):1335-42. PubMed ID: 11688717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR structure and dynamics of the engineered fluorescein-binding lipocalin FluA reveal rigidification of beta-barrel and variable loops upon enthalpy-driven ligand binding.
    Mills JL; Liu G; Skerra A; Szyperski T
    Biochemistry; 2009 Aug; 48(31):7411-9. PubMed ID: 19603796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative binding proteins: anticalins - harnessing the structural plasticity of the lipocalin ligand pocket to engineer novel binding activities.
    Skerra A
    FEBS J; 2008 Jun; 275(11):2677-83. PubMed ID: 18435758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrafast electron transfer in the complex between fluorescein and a cognate engineered lipocalin protein, a so-called anticalin.
    Götz M; Hess S; Beste G; Skerra A; Michel-Beyerle ME
    Biochemistry; 2002 Mar; 41(12):4156-64. PubMed ID: 11900559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuning ligand affinity, specificity, and folding stability of an engineered lipocalin variant -- a so-called 'anticalin' -- using a molecular random approach.
    Schlehuber S; Skerra A
    Biophys Chem; 2002 May; 96(2-3):213-28. PubMed ID: 12034442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of an artificial receptor protein ("anticalin") based on the human apolipoprotein D.
    Vogt M; Skerra A
    Chembiochem; 2004 Feb; 5(2):191-9. PubMed ID: 14760740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of ribosome display library based on lipocalin scaffold and screening anticalins with specificity for estradiol.
    Liu J; Ning B; Liu M; Sun Y; Sun Z; Zhang Y; Fan X; Zhou Z; Gao Z
    Analyst; 2012 May; 137(10):2470-9. PubMed ID: 22489281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small antibody-like proteins with prescribed ligand specificities derived from the lipocalin fold.
    Beste G; Schmidt FS; Stibora T; Skerra A
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):1898-903. PubMed ID: 10051566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High level expression and rational mutagenesis of a designed protein, the minibody. From an insoluble to a soluble molecule.
    Bianchi E; Venturini S; Pessi A; Tramontano A; Sollazzo M
    J Mol Biol; 1994 Feb; 236(2):649-59. PubMed ID: 8107147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel type of receptor protein, based on the lipocalin scaffold, with specificity for digoxigenin.
    Schlehuber S; Beste G; Skerra A
    J Mol Biol; 2000 Apr; 297(5):1105-20. PubMed ID: 10764576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and thermodynamic characterization of molten globule states of periplasmic binding proteins.
    Prajapati RS; Indu S; Varadarajan R
    Biochemistry; 2007 Sep; 46(36):10339-52. PubMed ID: 17696409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resonance assignments for the 21 kDa engineered fluorescein-binding lipocalin FluA.
    Liu G; Mills JL; Hess TA; Kim S; Skalicky JJ; Sukumaran DK; Kupce E; Skerra A; Szyperski T
    J Biomol NMR; 2003 Oct; 27(2):187-8. PubMed ID: 12913418
    [No Abstract]   [Full Text] [Related]  

  • 15. An antibody loop replacement design feasibility study and a loop-swapped dimer structure.
    Clark LA; Boriack-Sjodin PA; Day E; Eldredge J; Fitch C; Jarpe M; Miller S; Li Y; Simon K; van Vlijmen HW
    Protein Eng Des Sel; 2009 Feb; 22(2):93-101. PubMed ID: 19074157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering of a femtomolar affinity binding protein to human serum albumin.
    Jonsson A; Dogan J; Herne N; Abrahmsén L; Nygren PA
    Protein Eng Des Sel; 2008 Aug; 21(8):515-27. PubMed ID: 18499681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical purification and partial characterization of a murine macrophage surface receptor possessing specificity for small aromatic moieties including fluorescein.
    Cherukuri A; Nelson J; Voss EW
    J Mol Recognit; 1999; 12(2):94-102. PubMed ID: 10398400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A recombinant glutamine-binding protein from Escherichia coli: effect of ligand-binding on protein conformational dynamics.
    Herman P; Vecer J; Scognamiglio V; Staiano M; Rossi M; D'Auria S
    Biotechnol Prog; 2004; 20(6):1847-54. PubMed ID: 15575721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-guided engineering of Anticalins with improved binding behavior and biochemical characteristics for application in radio-immuno imaging and/or therapy.
    Eggenstein E; Eichinger A; Kim HJ; Skerra A
    J Struct Biol; 2014 Feb; 185(2):203-14. PubMed ID: 23542582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermodynamic effects of proline introduction on protein stability.
    Prajapati RS; Das M; Sreeramulu S; Sirajuddin M; Srinivasan S; Krishnamurthy V; Ranjani R; Ramakrishnan C; Varadarajan R
    Proteins; 2007 Feb; 66(2):480-91. PubMed ID: 17034035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.